NASDAQ:SIGA - Nasdaq - US8269171067 - Common Stock - Currency: USD
Taking everything into account, SIGA scores 7 out of 10 in our fundamental rating. SIGA was compared to 198 industry peers in the Pharmaceuticals industry. Both the health and profitability get an excellent rating, making SIGA a very profitable company, without any liquidiy or solvency issues. A decent growth rate in combination with a cheap valuation! Better keep an eye on SIGA. These ratings could make SIGA a good candidate for value and quality investing.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 24.23% | ||
ROE | 27.44% | ||
ROIC | 24.83% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 50.45% | ||
PM (TTM) | 42.69% | ||
GM | 77.44% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | 0 | ||
Altman-Z | 11.39 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 9.12 | ||
Quick Ratio | 7.16 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 9.05 | ||
Fwd PE | 3.52 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 8.89 | ||
EV/EBITDA | 3.86 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 10.02% |
6.065
+0.08 (+1.25%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 10.02% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 9.05 | ||
Fwd PE | 3.52 | ||
P/S | 3.12 | ||
P/FCF | 8.89 | ||
P/OCF | 8.89 | ||
P/B | 2.01 | ||
P/tB | 2.02 | ||
EV/EBITDA | 3.86 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 24.23% | ||
ROE | 27.44% | ||
ROCE | 31.96% | ||
ROIC | 24.83% | ||
ROICexc | 85.49% | ||
ROICexgc | 86.71% | ||
OM | 50.45% | ||
PM (TTM) | 42.69% | ||
GM | 77.44% | ||
FCFM | 35.12% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | 0 | ||
Debt/EBITDA | 0 | ||
Cap/Depr | 7.89% | ||
Cap/Sales | 0.03% | ||
Interest Coverage | 250 | ||
Cash Conversion | 69.14% | ||
Profit Quality | 82.28% | ||
Current Ratio | 9.12 | ||
Quick Ratio | 7.16 | ||
Altman-Z | 11.39 |